The current financial score of Acadia Healthcare Company Inc is 7.57. Its financial status is weak, and its operating efficiency is high. Its latest quarterly revenue reached 865.84M, representing a year-over-year decrease of 0.39%, while its net profit experienced a year-over-year decrease of 63.73%.
The current valuation score of Acadia Healthcare Company Inc is 7.78. Its current P/E ratio is -2.32, which is -1316.35% below the recent high of 28.24 and -49798.71% above the recent low of -1158.35.
The current earnings forecast score of Acadia Healthcare Company Inc is 7.43. The average price target is 33.57, with a high of 41.00 and a low of 17.00.
The current price momentum score of Acadia Healthcare Company Inc is 4.96. Currently, the stock price is trading between the resistance level at 31.92 and the support level at 25.68, making it suitable for range-bound swing trading.
The current institutional shareholding score of Acadia Healthcare Company Inc is 10.00. The latest institutional shareholding proportion is 133.17%, representing a quarter-over-quarter decrease of 6.86%. The largest institutional shareholder is HOTCHKIS & WILEY, holding a total of 278.28K shares, representing 0.02% of shares outstanding, with 3.26% increase in holdings.
The current risk assessment score of Acadia Healthcare Company Inc is 4.65. The company's beta value is 0.71. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.